NASDAQ
Anebulo Pharmaceuticals, Inc. (ANEB) has a current ratio of 53.36x as of Monday, May 25, 2026. This represents a 47.83% increase compared to its 12-month average of 36.10x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.